about
Rap1GAP interacts with RET and suppresses GDNF-induced neurite outgrowthVEGF is an essential mediator of the neurogenic and behavioral actions of antidepressantsGata3 acts downstream of beta-catenin signaling to prevent ectopic metanephric kidney inductionThe Concise Guide to PHARMACOLOGY 2013/14: catalytic receptors.c-RET molecule in malignant melanoma from oncogenic RET-carrying transgenic mice and human cell linesNormalization of the lymph node T cell stromal microenvironment in lpr/lpr mice is associated with SU5416-induced reduction in autoantibodies.Vascular endothelial growth factor receptor 1 contributes to Escherichia coli K1 invasion of human brain microvascular endothelial cells through the phosphatidylinositol 3-kinase/Akt signaling pathway.Phenotypic and gene expression modification with normal brain aging in GFAP-positive astrocytes and neural stem cells.Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterizationDeoxycholate promotes survival of breast cancer cells by reducing the level of pro-apoptotic ceramide.Functional RET G691S polymorphism in cutaneous malignant melanoma.Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphomaMolecular diagnosis of primary hyperparathyroidism in familial cancer syndromes.Current understanding of the molecular biology of pancreatic neuroendocrine tumors.NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922New targeted molecular therapies for dedifferentiated thyroid cancer.Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes.Systematic Analysis of Tyrosine Kinase Inhibitor Response to RET Gatekeeper Mutations in Thyroid Cancer.The actions of relaxin on the human cardiovascular system.Design, synthesis, and biological activity of urea derivatives as anaplastic lymphoma kinase inhibitors.
P2860
Q24301386-36781829-8776-4517-8A2B-1A2F5308929BQ28579192-037BE651-C285-4A36-9403-3975C94213DDQ28579892-CFF3E318-F02F-401D-9883-C37A43562484Q30486741-73C97001-F153-4558-8E8B-B8B88330B516Q33565577-4E908853-0367-4C97-A505-C87CC730541FQ34193426-020CF41B-2197-43EC-A2EF-3C3075BAD189Q34290785-72EDFAF3-74E6-46FB-8246-8D5F45B455B4Q34981292-F5524353-DC17-41B5-849B-7CFE2310DE89Q36960380-8199452E-3B45-440F-9130-E642382D82D0Q37131369-27067D25-E86D-4D43-BF11-FAB868830FB4Q37334690-F9315E1C-A5AB-4386-BB3A-2B119A3262B5Q37687313-9CF26917-36B3-4273-8B9A-BA7BBC40A557Q38089260-72837495-DF82-4318-B065-39AF313AC095Q38120515-71A28D43-2027-4458-B359-3D7211457E33Q38902511-B1B2CA1A-C125-4D16-972D-06D75888A034Q42734670-CA14BD76-536E-490F-9B4A-5225CC8165F0Q47601932-277E87EE-83F0-418D-ACF3-0CD16FB686DCQ49010203-11BF4B5E-68C8-4961-951B-33BA0B6BD417Q52851745-AF771C71-72CE-4F55-8CC0-FABD79B20F8CQ54577546-33D0FF81-617F-46E0-AD26-2BB036F27ABE
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Inhibition of RET tyrosine kinase by SU5416.
@en
Inhibition of RET tyrosine kinase by SU5416.
@nl
type
label
Inhibition of RET tyrosine kinase by SU5416.
@en
Inhibition of RET tyrosine kinase by SU5416.
@nl
prefLabel
Inhibition of RET tyrosine kinase by SU5416.
@en
Inhibition of RET tyrosine kinase by SU5416.
@nl
P2093
P356
P1476
Inhibition of RET tyrosine kinase by SU5416.
@en
P2093
Barbara Riva
Elisa Sala
Franca Formelli
Jenny Bain
Leonardo Scapozza
Luca Mologni
Miriam Puttini
Roberta Rostagno
Sara Cazzaniga
Sara Redaelli
P304
P356
10.1677/JME.1.01999
P577
2006-10-01T00:00:00Z